Summary
Lisdexamfetamine dimesylate was statistically superior to osmotic controlled-release methylphenidate in a forced-dose study of adolescents with attention-deficit/hyperactivity disorder but failed to meet standards of statistical significance in a flexible-dose version of the study.
- ADHD
- lisdexamfetamine dimesylate
- LDX
- methylphenidate
- OROS-MPH
- attention-deficit/hyperactivity disorder
- Clinical Global Impressions–Improvement
- child & adolescent psychiatry
- psychiatry & psychology clinical trials
- © 2015 SAGE Publications
Tools
Fixed-Dose Lisdexamfetamine More Effective Than Methylphenidate in Adolescents With ADHD
Permalink:
Table of contents
Cited By...
- No citing articles found.